Thus, ILE 20% not only reversed the central nervous system symptom of intoxication such as catalepsy, but also could reverse peripheral manifestations of HA intoxication.
Known as the STAR system ("Symptom Tracking and Reporting"), this system was initially developed for use by patients receiving outpatient chemotherapy and was found to be feasible for both clinic-based and home-based internet reporting in diverse populations, including those with no prior computer experience, lower educational levels, and high symptom burdens[ 12, 13].
AIDS slowly attacks the immune system; symptoms take about 10 years to appear.
A second group has nervous system symptoms like memory loss, confusion, fatigue, muscle weakness and numbness or tingling.
By incorporating physics of failure models into component, the dynamic process of a failing or degrading component can be projected onto system behavior, i.e., system symptoms.
Human parechovirus type 1 (HPeV-1) appears to be associated with gastrointestinal and respiratory infections, and occasionally with central nervous system symptoms.
Chronic pain, central nervous system symptoms, gastrointestinal symptoms, and gynecological problems are all more common in victims of IPV [2].
Central nervous system symptoms, consistent with solvent exposure including lightheadedness, fatigue, increased sleep requirement and headache, are described [1].
Besides head pain, sensitivity to light or sound and some vegetative features, such as nausea, migraine is characterised by additional central nervous system symptoms, including neck stiffness, concentration problems, tiredness, irritability and craving [10].
Migraine is viewed as an inherited brain disorder, characterized by neurotransmitter imbalances leading to neuronal dysfunctions, which then present with recurrent headache attacks and combinations of gastrointestinal and autonomic nervous system symptoms [1].
The Human Genetic Therapies segment offers products, including FIRAZYR for the treatment of acute hereditary angioedema, REPLAGAL for fabry disease and HGT-2310 for the treatment of Hunter syndrome with central nervous system symptoms, idursulfase-intrathecal delivery.
